0.388
+0.038
(10.86%)
After Hours: 0.510
+0.122
(31.44%)
May 21, 4:00pm GMT-4
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
| Range | 0.36 - 0.39 |
| 52 week | 0.20 - 1.25 |
| Open | 0.39 |
| Vol / Avg. | 54,739.00/18,323.00 |
| Mkt cap | 2.50M |
| P/E | - |
| Div/yield | - |
| EPS | -0.16 |
| Shares | 6.43M |
| Beta | 0.24 |
| Inst. own | 0% |
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | - | - |
| Operating margin | - | - |
| EBITD margin | - | - |
| Return on average assets | -606.92% | -473.93% |
| Return on average equity | - | -1255.12% |
| Employees | 2 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite 202, 27936 Lost Canyon Road
SANTA CLARITA, CA 91387
United States - Map
+1-661-2510001 (Phone)
+1-661-2510003 (Fax)
SANTA CLARITA, CA 91387
United States - Map
+1-661-2510001 (Phone)
+1-661-2510003 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
BioSolar, Inc. (Biosolar) is developing a technology to produce bio-based materials from renewable plant sources. The Company is focusing its research and product development efforts on producing bio-based components that meet the thermal requirements of current solar module manufacturing processes. The Company is focusing its research and product development efforts on bio-based backsheets, substrates, superstrates, module and panel components. BioSolar develops and produces bio-based components. As of December 31, 2011, the Company had developed multiple versions of its bio-based backsheet. Biobacksheet obtained Underwriters Laboratories' (UL) material certification in February 2011.
Officers and directors
| David D. Lee | Chief Executive Officer, Acting Chief Financial Officer, Director | |
| Stanley Burton Levy | Vice President, Chief Technology Officer | |
| Dennis LePon | Director | |
| Steven C. Bartling | Independent Director |